Effect of Chlorhexidine Gluconate before Peripheral Intravenouscannulation on Phlebitis
Schlagwörter:
Peripheral intravenous cannulation, Phlebitis, ChlorhexidineAbstract
Phlebitis is one of the most common complications of peripheral inserted catheter that may occur in upto 75% of hospitalized patients. The center for disease control and prevention guidelines recommend a 2% chlorhexidine-based preparation, tincture of iodine, iodophor or 70% isopropyl alcohol for skin antisepsis prior to insertion of intravenous catheters. The present study was conducted to assess the effect of ‘2.5% chlorhexidine gluconate with 70% ethyl alcohol’ before peripheral intravenous cannulation on phlebitis. Using consecutive sampling, 200 subjects were studied 100 each in experimental and control group. 2.5% chlorhexidine gluconate with 70% ethyl alcohol was used as skin antisepsis before peripheral intravenous cannulation among experimental group. Assessment of phlebitis was done using visual infusion phlebitis scale in both the groups. Mean age (yrs) ± SD of study subjects were 42.49 ±15.20 and 40.26 ±16.40 in experimental and control group, respectively. Mean duration of cannula in situ was 2.66 days ± 0.75SD. The incidence of phlebitis was 54 and 59% in experimental and control group, respectively, and was statistically non-significant (p>0.05).Although, there was no significant difference between using chlorhexidine and isopropyl alcohol on prevention of phlebitis, but incidence of phlebitis in experimental group was lower than control group, so it is suggested as a selected solution for disinfection of catheter insertion site.Veröffentlicht
Ausgabe
Rubrik
Lizenz
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
· I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
· I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
· I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
· I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
_______________
We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |